Addus HomeCare News

Buy Rating Justified by Addus Homecare's Strategic Growth and Operational Efficiency

TipRanksMay 15 17:55

Addus HomeCare Is Maintained at Buy by TD Cowen

Addus HomeCare Is Maintained at Buy by TD Cowen

Dow JonesMay 10 00:28

TD Cowen: Maintaining the Addus HomeCare (ADUS.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $105.00 to $119.00.

TD Cowen: Maintaining the Addus HomeCare (ADUS.US) rating, adjusted from buy to buy rating, and the target price was adjusted from $105.00 to $119.00.

Zhitong FinanceMay 10 00:20

TD Cowen Maintains Buy on Addus HomeCare, Raises Price Target to $119

TD Cowen analyst Ryan Langston maintains Addus HomeCare (NASDAQ:ADUS) with a Buy and raises the price target from $105 to $119.

BenzingaMay 10 00:17

Here's Why We Think Addus HomeCare (NASDAQ:ADUS) Is Well Worth Watching

Investors are often guided by the idea of discovering 'the next big thing', even if that means buying 'story stocks' without any revenue, let alone profit.

Simply Wall StMay 8 18:47

The Zacks Analyst Blog Highlights DaVita, Option Care Health, Addus HomeCare, Encompass Health and The Pennant

Yahoo FinanceMay 8 17:59

Addus HomeCare Corp (ADUS) Q1 2024 Earnings Call Transcript Highlights: Strong Growth and ...

Yahoo FinanceMay 8 15:24

Addus HomeCare | 10-Q: Quarterly report

Futu NewsMay 8 04:39 · Announcements

Addus HomeCare to Participate in BofA Securities Health Care Conference 2024

Addus HomeCare Corporation (NASDAQ:ADUS), a provider of home care services, today announced that Dirk Allison, Chairman and Chief Executive Officer, Brad Bickham, President and Chief Operating Officer, and Brian Poff,

BusinesswireMay 7 23:00

Stephens & Co. Reiterates Overweight on Addus HomeCare, Maintains $115 Price Target

Stephens & Co. analyst Scott Fidel reiterates Addus HomeCare with a Overweight and maintains $115 price target.

Analyst UpgradesMay 7 22:12

Analysts' Opinions Are Mixed on These Healthcare Stocks: Addus Homecare (ADUS), BioCryst (BCRX) and Syndax Pharmaceuticals (SNDX)

TipRanksMay 7 20:21

Addus Homecare (ADUS) Receives a Rating Update From a Top Analyst

TipRanksMay 7 20:17

Addus HomeCare Is Maintained at Buy by B of A Securities

Addus HomeCare Is Maintained at Buy by B of A Securities

Dow JonesMay 7 19:06

B of A Securities Maintains Buy on Addus HomeCare, Raises Price Target to $118

B of A Securities analyst Joanna Gajuk maintains Addus HomeCare (NASDAQ:ADUS) with a Buy and raises the price target from $115 to $118.

BenzingaMay 7 18:56

Addus HomeCare Q1 Adjusted Earnings, Revenue Advance

Addus HomeCare (ADUS) reported Q1 adjusted earnings late Monday of $1.21 per diluted share, up from $0.97 a year earlier. Analysts polled by Capital IQ expected $1.09. Revenue for the quarter ended Ma

MT NewswiresMay 7 18:11

Addus Homecare: A Robust Financial Performance and Bullish Stock Outlook

TipRanksMay 7 17:19

Compared to Estimates, Addus HomeCare (ADUS) Q1 Earnings: A Look at Key Metrics

Yahoo FinanceMay 7 06:30

Earnings Flash (ADUS) ADDUS HOMECARE CORPORATION Reports Q1 Revenue $280.7M, Vs. Street Est of $280.4M

04:19 PM EDT, 05/06/2024 (MT Newswires) -- Earnings Flash (ADUS) ADDUS HOMECARE CORPORATION Reports Q1 Revenue $280.7M, vs. Street Est of $280.4M

MT NewswiresMay 7 04:19

Addus HomeCare Q1 2024 Adj EPS $1.21 Beats $1.09 Estimate, Sales $280.700M Beat $279.564M Estimate

Addus HomeCare (NASDAQ:ADUS) reported quarterly earnings of $1.21 per share which beat the analyst consensus estimate of $1.09 by 11.01 percent. The company reported quarterly sales of $280.700 milli

BenzingaMay 7 04:10

Press Release: Addus HomeCare Announces First Quarter 2024 Financial Results

Addus HomeCare Announces First Quarter 2024 Financial Results FRISCO, Texas--(BUSINESS WIRE)--May 06, 2024-- Addus HomeCare Corporation (NASDAQ: ADUS), a provider of home care services, today announ

Dow JonesMay 7 04:06